Pharmafile Logo

ProClinica Inc.

ProClinica was founded in 1975 by its president, Mel Snyder, and quickly developed a world-wide reputation for its unique sales-supportive educational/promotional programs: Sponsored CME programs, sales training programs, sales aids, journal advertising and professional/public relations programs. ProClinica’s clients and their best-remembered products include NEN/DuPont Imaging (thallium-201 imaging), Cutter Laboratories (Intralipid), Boots Laboratories (Synthroid, E-Mycin), and Campbell Soup (Intelligent Quisine). And the client execs and physicians with whom we developed them are as proud of those programs as we are.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

10 Albion Avenue, Stoneham, MA, 2180, United States
+1 866-777-1770

 Latest Content from PMHub 

OPEN Health Appoints Peter Black as EVP, Global Client Partner and Transformation Lead to Accelerate Global Client Partnerships and Digital Innovation

Press Releases | March 18, 2026 | OPEN Health

OPEN Health today announced the appointment of Peter Black as EVP, Global Client Partner and Transformation Lead.

OPEN Health Appoints Cara Priest as Chief People Officer to Strengthen Culture, Capability and Organisational Performance

Press Releases | March 18, 2026 | OPEN Health

OPEN Health today announced the appointment of Cara Priest as Chief People Officer, reinforcing the company’s commitment to building a high-performing culture that supports its continued growth and scientific excellence.

Smarter Learning and Better Outcomes: How AI Can Provide an Advantage in Medical Education

Press Releases | March 12, 2026 | Impetus Digital

See how AI-powered patient avatars allow physicians to test complex diagnoses and treatment plans in a simulated environment.

Webinar: What do HCPs really want from pharma digital in 2026?

Our research shows that healthcare professionals are not disengaging from pharma digital. They are becoming more selective about the experiences that earn their attention. To explore what this means for...

Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.

At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...

AI in practice: 4 real-world use cases in health and life sciences

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...

A Pharma Brand Manager’s Guide to Exhibiting

Securing your exhibition space is a significant milestone. The contract is signed, the floorplan is confirmed and the event is in the calendar. So what happens next? Exhibiting successfully involves...

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Why stigma is a launch risk in rare disease – and what commercial leaders can do about it

Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.